Ataxia and Seizure as a Manifestation in a Pediatric Case of SARS-CoV-2

Main Article Content

Farzad Ahmadabadi
Amirmohammad Abdolmohammadzadeh
Negin Nahanmoghaddam
Faramarz Ajri

Abstract

Background: SARS-CoV-2 infection is an ongoing pandemic with more than seven million cases worldwide and a wide range of presenting symptoms in various ages. Neurological symptoms as mildly as a light headache and as severe as an acute encephalitis are reported.

Objective: We aim to report the clinical course of pediatric patient infected with SARS-CoV-2 whom also presented ataxia and seizures as her neurological manifestation.

Case: Patient was a 16 month old baby girl with clinical presentations of ataxia, focal myoclonic seizures, fever and diarrhea and no significant medical history. Her seizures were controlled with sodium valproate along with carnitine.  She developed respiratory symptoms after her RT-PCR test from her nasopharyngeal sample swap returned with positive results. We ruled out a wide range of disease such as paraneoplastic and metabolic disorders. Patient was discharged with full recovery after receiving IVIG.

Discussion: We believe there is a post infectious mechanism involved that has lead the patient to have such neurological manifestations because of a significant response to IVIG while she also presented typical finds in children infected with SARS-CoV-2. Patients with SARS-CoV-2 infection can have neurological manifestations despite their negative RT-PCR test for SARS-CoV-2 in their cerebrospinal fluid.

Conclusion: During the pandemic, every practitioner should have SARS-CoV-2 infection in mind when it comes to neurological manifestations without a strongly-associated explanation.

Keywords:
SARS-CoV-2, pediatrics, seizure, ataxia, case report.

Article Details

How to Cite
Ahmadabadi, F., Abdolmohammadzadeh, A., Nahanmoghaddam, N., & Ajri, F. (2020). Ataxia and Seizure as a Manifestation in a Pediatric Case of SARS-CoV-2. Asian Journal of Case Reports in Medicine and Health, 3(4), 6-11. Retrieved from https://journalajcrmh.com/index.php/AJCRMH/article/view/30136
Section
Case Report

References

Jin Y, et al. Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses. 2020;12(4).

WHO, Coronavirus Disease (COVID-2019) Situation Report 164; 2020.

Koralnik IJ, Tyler KL. COVID-19: A global threat to the nervous system. Ann Neurol; 2020.

Zhou Z, et al. Understanding the neurotropic characteristics of SARS-CoV-2: From neurological manifestations of COVID-19 to potential neurotropic mechanisms. J Neurol. 2020;1-6.

Yang W, et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): A multi-center study in Wenzhou city, Zhejiang, China. J Infect. 2020;80(4):388-393.

Garazzino S, et al. Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020. Euro Surveill. 2020;25(18).

Moriguchi T, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55-58.

Lu X, et al. SARS-CoV-2 infection in children. N Engl J Med. 2020;382(17): 1663-1665.

Xu Y, et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med. 2020;26(4):502-505.

Li Y, et al. Insight into COVID-2019 for pediatricians. Pediatr Pulmonol. 2020; 55(5):E1-e4.

De Rose DU, et al. Novel coronavirus disease (COVID-19) in newborns and infants: What we know so far. Ital J Pediatr. 2020;46(1):56.

Ahmadabadi F, et al. Three cases of acute necrotizing encephalopathy: Is it an epidemic or only incidental. Iranian Journal of Child Neurology. 2020;14(2):87-92.

Davies E, Connolly DJ, Mordekar SR. Encephalopathy in children: An approach to assessment and management. Arch Dis Child. 2012;97(5):45.